1. Home
  2. CSBR vs SAMG Comparison

CSBR vs SAMG Comparison

Compare CSBR & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • SAMG
  • Stock Information
  • Founded
  • CSBR 1985
  • SAMG 2002
  • Country
  • CSBR United States
  • SAMG United States
  • Employees
  • CSBR N/A
  • SAMG N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • SAMG Investment Managers
  • Sector
  • CSBR Health Care
  • SAMG Finance
  • Exchange
  • CSBR Nasdaq
  • SAMG Nasdaq
  • Market Cap
  • CSBR 135.5M
  • SAMG 155.5M
  • IPO Year
  • CSBR 1986
  • SAMG 2013
  • Fundamental
  • Price
  • CSBR $8.61
  • SAMG $16.54
  • Analyst Decision
  • CSBR Strong Buy
  • SAMG
  • Analyst Count
  • CSBR 1
  • SAMG 0
  • Target Price
  • CSBR $12.00
  • SAMG N/A
  • AVG Volume (30 Days)
  • CSBR 44.2K
  • SAMG 37.3K
  • Earning Date
  • CSBR 03-11-2025
  • SAMG 03-06-2025
  • Dividend Yield
  • CSBR N/A
  • SAMG 4.89%
  • EPS Growth
  • CSBR N/A
  • SAMG 4.17
  • EPS
  • CSBR 0.46
  • SAMG 1.00
  • Revenue
  • CSBR $58,591,000.00
  • SAMG $123,651,000.00
  • Revenue This Year
  • CSBR $14.19
  • SAMG $8.52
  • Revenue Next Year
  • CSBR $10.11
  • SAMG $3.95
  • P/E Ratio
  • CSBR $18.82
  • SAMG $16.36
  • Revenue Growth
  • CSBR 19.03
  • SAMG 5.32
  • 52 Week Low
  • CSBR $3.60
  • SAMG $13.93
  • 52 Week High
  • CSBR $11.99
  • SAMG $19.20
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 39.31
  • SAMG 40.86
  • Support Level
  • CSBR $9.21
  • SAMG $15.97
  • Resistance Level
  • CSBR $9.97
  • SAMG $16.68
  • Average True Range (ATR)
  • CSBR 0.65
  • SAMG 0.37
  • MACD
  • CSBR -0.10
  • SAMG 0.02
  • Stochastic Oscillator
  • CSBR 15.74
  • SAMG 43.51

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

Share on Social Networks: